Aurobindo Pharma (NSE:AUROPHARMA, BOM:524804) said its wholly owned step-down subsidiary, PT Aurogen Pharma Indonesia, has incorporated PT Auro Pharm Indonesia as a wholly owned subsidiary in Indonesia.
The new company will undertake manufacturing operations in Indonesia and has an initial subscribed share capital of 20 billion Indonesian rupiah, according to a stock exchange filing.